MDC Partners acquires a majority stake in Concentric

Share this article:

New York indie agency Concentric Pharma Advertising announced that business transfer organization MDC Partners has acquired a majority stake in the firm. It's MDC Partners' first significant stake in healthcare marketing in the US, though the company's mainline advertising investments include Crispin Porter + Bogusky.

With offices in New York and London, Concentric's roster of pharma clients includes Pfizer, Novartis, Amgen, Allergan and Genentech. The company also boasts agency-of-record status on Pfizer and Amgen's Enbrel for rheumatology. The companies declined to disclose financial details on the deal.

“Clients in this sector are increasingly seeking to go beyond outdated one-size-fits-all approaches and find true evolution,” said MDC chief Miles Nadal. “The partnership between Concentric and MDC Partners launches a network model that integrates sophisticated multichannel strategies from the most cutting-edge agencies in the world and applies them to the needs of healthcare using Concentric as the knowledge portal into the industry.”

“We were only interested in partnering with a company that was willing to innovate—to completely reinvent the model—and at the same time matched our entrepreneurial spirit,” said Concentric chief Ken Begasse, Jr. “Having worked with MDC for 18 months prior to our formal acquisition, we knew Concentric would have the opportunity, flexibility and resources to build a healthcare network that actually works.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?